Your browser doesn't support javascript.
loading
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Adnan Awad, Shady; Dufva, Olli; Ianevski, Aleksandr; Ghimire, Bishwa; Koski, Jan; Maliniemi, Pilvi; Thomson, Daniel; Schreiber, Andreas; Heckman, Caroline A; Koskenvesa, Perttu; Korhonen, Matti; Porkka, Kimmo; Branford, Susan; Aittokallio, Tero; Kankainen, Matti; Mustjoki, Satu.
Afiliação
  • Adnan Awad S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Dufva O; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Ianevski A; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Ghimire B; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Koski J; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Maliniemi P; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Thomson D; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Schreiber A; Department of Computer Science, Helsinki Institute for Information Technology (HIIT), Aalto University, Espoo, Finland.
  • Heckman CA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Koskenvesa P; Finnish Red Cross Blood Service, Helsinki, Finland.
  • Korhonen M; Finnish Red Cross Blood Service, Helsinki, Finland.
  • Porkka K; Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
  • Branford S; Division of Health Sciences, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.
  • Aittokallio T; Division of Health Sciences, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.
  • Kankainen M; Australian Cancer Research Foundation Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
  • Mustjoki S; School of Biological Sciences, University of Adelaide, Adelaide, Australia.
Leukemia ; 35(4): 1087-1099, 2021 04.
Article em En | MEDLINE | ID: mdl-32782381
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Crise Blástica / Subunidade alfa 2 de Fator de Ligação ao Core / Transcriptoma / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Crise Blástica / Subunidade alfa 2 de Fator de Ligação ao Core / Transcriptoma / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article